控制抗菌药物耐药性面临的长寿和气候变化双重挑战。
The twin challenges of longevity and climate change in controlling antimicrobial resistance.
机构信息
Research Center for Antibiotic Stewardship and Antimicrobial Resistance, Infectious Diseases Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Virology Department of Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
出版信息
J Antibiot (Tokyo). 2024 Jul;77(7):399-402. doi: 10.1038/s41429-024-00730-6. Epub 2024 May 9.
Antimicrobial resistance (AMR) is one of the global health challenges of the 21st century that is faced with the twin threats of global climate change and greater longevity, which pose a synergistic risk to the management of AMR. Antimicrobial agents are in high demand due to the challenges faced by increasing life expectancy and the dynamic changes in disease ecology prompted by climate change. In light of global aging and climate change, the complexity and importance of addressing antibiotic resistance are further highlighted by this interplay of issues.
抗微生物药物耐药性（AMR）是 21 世纪全球健康面临的挑战之一，同时还面临着全球气候变化和预期寿命延长的双重威胁，这对 AMR 的管理构成了协同风险。由于预期寿命延长所面临的挑战以及气候变化导致的疾病生态学的动态变化，对抗微生物药物的需求不断增加。鉴于全球人口老龄化和气候变化，这些问题的相互作用进一步突出了解决抗生素耐药性问题的复杂性和重要性。
Zotero 插件